[HTML][HTML] Risk factors for thyroid cancer: what do we know so far?

TB Crnčić, MI Tomaš, N Girotto… - Acta Clinica Croatica, 2020 - ncbi.nlm.nih.gov
Thyroid cancer (TC) is the most common endocrine cancer today. The rising incidence of the
differentiated papillary type cannot be entirely explained by early and meticulous diagnosis …

[HTML][HTML] Role of prophylactic central neck lymph node dissection for papillary thyroid carcinoma in the era of de-escalation

ET Pavlidis, TE Pavlidis - World Journal of Clinical Oncology, 2023 - ncbi.nlm.nih.gov
Thyroid cancer is the most common endocrine malignancy. While there has been no
appreciable increase in the observed mortality of well-differentiated thyroid cancer, there …

The role of MMP-9 and MMP-9 inhibition in different types of thyroid carcinoma

Z Li, J Wei, B Chen, Y Wang, S Yang, K Wu, X Meng - Molecules, 2023 - mdpi.com
Matrix metalloproteinase-9 (MMP-9), one of the most investigated and studied biomarkers of
the MMPs family, is a zinc-dependent proteolytic metalloenzyme whose primary function is …

Prognostic and therapeutic role of angiogenic microenvironment in thyroid cancer

A Melaccio, LI Sgaramella, A Pasculli, G Di Meo… - Cancers, 2021 - mdpi.com
Simple Summary Angiogenesis is an essential event for the progression of solid tumors and
is promoted by angiogenic cytokines released in the tumor microenvironment by neoplastic …

FAM83B promotes the invasion of primary lung adenocarcinoma via PI3K/AKT/NF-κB pathway

J Zhang, J Wang, K Yue, P Li, W Shen, X Qiao… - BMC Pulmonary …, 2023 - Springer
Abstract Objects The family with sequence similarity 83B (FAM83B) is one of the markers for
poor prognosis in several carcinomas, but the expression and the mechanism resulted in …

The thyroid tumor microenvironment: potential targets for therapeutic intervention and prognostication

L MacDonald, J Jenkins, G Purvis, J Lee… - Hormones and Cancer, 2020 - Springer
Thyroid cancer is the most common endocrine malignancy and incidences are rising rapidly,
in both pediatric and adult populations. Many thyroid tumors are successfully treated which …

Role of matrix metalloproteinases and their inhibitors in locally invasive papillary thyroid cancer

I Ivković, Z Limani, A Jakovčević, D Huić, D Prgomet - Biomedicines, 2022 - mdpi.com
Locally invasive papillary thyroid carcinoma (PTC) protrudes beyond the thyroid capsule
and invades local structures. Matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) …

[HTML][HTML] Prophylactic central neck dissection in well-differentiated thyroid cancer

K Gršić, B Bumber, RC Radivojević… - Acta Clinica Croatica, 2020 - ncbi.nlm.nih.gov
Well-differentiated cancers, both papillary and follicular, account for 90% of all diagnosed
thyroid cancers. They have an indolent disease course with a 20-year disease-specific …

CRLF1–MYH9 interaction regulates proliferation and metastasis of papillary thyroid carcinoma through the ERK/ETV4 axis

ST Yu, BH Sun, JN Ge, JL Shi, MS Zhu… - Frontiers in …, 2020 - frontiersin.org
In our previous study, we have shown that CRLF1 can promote proliferation and metastasis
of papillary thyroid carcinoma (PTC); however, the mechanism is unclear. Herein, we …

Predictive significance of two MMP-9 promoter polymorphisms and acetylated c-Jun transcription factor for papillary thyroid carcinoma advancement

J Rončević, J Janković Miljuš, T Išić Denčić, V Božić… - Diagnostics, 2022 - mdpi.com
Papillary thyroid carcinoma represents a challenge from a prognostic standpoint. Molecular
alterations responsible for PTC advancement include MMP-9 genetic promoter …